PCORI Health Care Horizon Scanning System: Biweekly COVID-19 Scans
In early 2020, the COVID-19 pandemic created a fast-moving, widespread public health crisis. In May 2020, PCORI expanded its PCORI Health Care Horizon Scanning System (HCHSS) to elucidate the landscape of potentially impactful applications for COVID-19. The HCHSS COVID-19 supplement scans for, identifies, monitors, and reports on emerging and available COVID-19-related treatments, diagnostics, preventive measures, management strategies, and systems changes with potential for high impact to patient outcomes—for individuals and populations—in the United States in the next 12 months.
These Biweekly COVID-19 Scans provide ECRI Horizon Scanning with a vehicle to inform PCORI and the public in a timely manner of important topics of interest identified during ongoing scanning and topic identification or through the ECRI stakeholder survey process.
Biweekly COVID-19 Scans
View Recently Published Biweekly Scans
- Treatment for Acute Respiratory Distress Syndrome, Breathalyzer to Detect Infection (April 14-27, 2022)
- Adoption of Decentralized Clinical Trials, Treatment for Mild to Moderate COVID-19 (March 31-April 13, 2022)
- Increasing Access to Antiviral Treatments, Vaccines for Children Aged 4 and Younger (March 17-30, 2022)
- Identifying Patients With Post-COVID Conditions, Administering Dental Health Care (March 3-16, 2022)
- Addressing Nursing Shortages, Decreased Routine Vaccination (February 17-March 2, 2022)
- Treating Mild to Moderate COVID-19, Addressing Health Care Staffing Shortages (February 3-16, 2022)
- Omicron-Specific mRNA Vaccines, Pediatric Recovery Programs (January 20-February 2, 2022)
- Treating Mild to Moderate COVID-19, Mental and Behavioral Health in Adolescents/Young Adults (January 6-19, 2022)
- Integrated Testing Platforms, Vaccine Mandates for Children (December 23, 2021-January 5, 2022)
- Three Potential Treatments for Long COVID (December 9-22, 2021)
- Bucillamine - Oral Anti-Inflammatory Drug, Direct-to-consumer Telehealth Platforms (November 25-December 5, 2021)
- School-located Vaccine Clinics, Test-to-Stay Risk Mitigation (November 11-24, 2021)
- Treatments for Hospitalized Patients and Patients with Mild to Moderate COVID-19 (October 28-November 10, 2021)
- Mobile Health Application, National Black Church Initiative (October 14-27, 2021)
- Treating COVID-19 Pneumonia and Mild to Moderate COVID-19 (September 30-October 13, 2021)
- Mental Health Screening in Schools, Post-Exposure Prophylaxis (September 16-29, 2021)
- C21 (VP01) for Severe COVID-19, Corneal Confocal Microscopy (September 2-15, 2021)
- Monoclonal Antibody Clinics, Vaccines for Children Under 12 Years (August 19-September 1, 2021)
- Additional Dose of mRNA Vaccine, Post-Exposure Prophylaxis (August 5-18, 2021)
- Deupirfenidone (LYT-100) to Treat Adults, Vaccine Mandates (July 22-August 4, 2021)
- Reinstating Mask Mandates, Potential Treatment for COVID-19 and ARDS (July 8-21, 2021)
- Treating COVID-19 With Respiratory Failure, WhatsApp Spanish Chat Initiative (June 24-July 7, 2021)
- Incentive Programs for Vaccine Uptake, Investigational Outpatient Treatment (June 10-23, 2021)
- Treating Mild to Moderate COVID-19, Hospital-to-Home Programs (May 27-June 9, 2021)
- Cognitive Rehabilitation Therapy, Tele-rehabilitation Programs (May 13-26, 2021)
- Treating Severe ARDS, COVID Test Initiative (April 29-May 12, 2021)
- Treating Patients Hospitalized with COVID-19 (April 15-28, 2021)
- Leftover Vaccine Doses, Detecting SARS-CoV-2 Variants (April 1-14, 2021)
- Treatments for Patients With Acute Respiratory Distress Syndrome (March 18-31, 2021)
- Drive-through Vaccination Clinics, Nitazoxanide (March 4-17, 2021)
- Digital Immunization Records, Variant-Specific Vaccines (February 20-March 3, 2021)
- Mental Health Services and Reducing Stress for Health Care Workers (February 6-19, 2021)
- Vaccines to Prevent Infections (January 23-February 5, 2021)
- Smartphone Applications, Surveillance Programs (January 9-22, 2021)
- Testing Impact Calculator, Ellume Home Test (December 24, 2020-January 8, 2021)
- Baricitinib and Remdesivir, Mobile Health Clinics (December 10-23, 2020)
- All-in-One Test Kit, RLF-100 (Aviptadill) (November 21-December 9, 2020)
- Vaccine Allocation Planner, Vaccine Safety Assessment for Essential Workers (November 12-20, 2020)
- CD24Fc (SACCOVID), Sepsis Diagnostic Tests (October 29-November 11, 2020)
- AI-Assisted Radiographic Image Assessment, Dual Point-of-Care Nucleic Acid Assays (October 15-28, 2020)
- Colchicine, Monoclonal Antibodies for Treating Patients with COVID-19 (October 1-14, 2020)
- College, University, and Employee Testing Programs (September 17-30, 2020)
- BinaxNOW COVID-19 Ag Card, Saliva-based Nucleic Acid Assays (September 3-16, 2020)
- Convalescent Plasma, Remdesivir (August 20-September 2, 2020)
- Next-Generation Sequencing Assays, Point-of-Care Breath Test (August 6-August 19, 2020)
- Negative-Pressure Tents, Reusable Silicone Respirators (July 23-August 5, 2020)
- Vaccines for Preventing Coronavirus Infection (July 9-July 22, 2020)
- Isolation Bags for Safe CT Imaging, Population-wide Antibody Testing (June 25-July 8, 2020)
- Point-of-Care Tests, Dexamethasone (June 11-June 24, 2020)
- Contact Tracing, mRNA Vaccine, Patient Load Management (May 28-June 10, 2020)
- Anakinra (Kineret) and Self-Collection Test Kit (May 14-May 27, 2020)
Commentary in COVID-19 Scans reflect preliminary views of ECRI Horizon Scanning and internal ECRI stakeholders.
The information contained in the documents has not been vetted by other stakeholders.
We welcome your comments on the Scans. Send them by email to [email protected]
or by mail to: Patient-Centered Outcomes Research Institute, 1828 L Street, NW, Suite 900, Washington, DC 20036.
What's Happening at PCORI?
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.
Image
